Eli Lilly of Indiana received permission for restricted emergency use from India's Central Drugs Standard Control Organization, for baricitinib in combination with remdesivir, for treatment of suspected or laboratory-confirmed coronavirus disease 2019 (COVID-19) in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation. The company has...
American Support To Battle India’s Covid Crisis
Just three days after declaring U.S. support for India's disastrous Covid-19 spread, the White House released a slew of specific actions supporting India in this battle: An initial delivery of 1,100 cylinders will remain in India and can be repeatedly refilled with oxygen at local supply centers, with more planeloads...
Another Covid-19 Vaccine Enters Production in India
India's Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorization in May or June, its managing director was quoted as saying, with an aim to make up to 240 million doses a year. Its DNA plasmid product - which involves the injection...
Defense Department Supports India’s Pandemic Response
According to CNN, the Defense Department will provide support to India for its Covid response, Defense Secretary Lloyd Austin announced Sunday. "I have directed the Department to use every resource at our disposal, within our authority, to support U.S. inter-agency efforts to rapidly provide India's front line healthcare workers with...
Washington Galvanizes as India Battles Covid-19 Tsunami
On April 6, 2020 , as the United States was pummeled by the Covid-19 pandemic, Time Magazine lamented how India had blocked exports of a malaria drug that held potential to treat novel coronavirus patients. The President of the United States tweeted asking India for help and within just six...
Lord Lister Visits India, Prepping for U.K. Prime Minister Visit
Lord Eddie Lister, Boris Johnson’s special envoy to the Gulf countries visited India to secure millions of doses of the Oxford/AstraZeneca vaccine being manufactured under license by India’s Serum Institute. Lister and international affairs adviser David Quarrey met India’s foreign secretary Harsh Shringla in New Delhi to “discuss bilateral relations...